Neil Josephson - Nov 10, 2021 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Chief Medical Officer
Signature
/s/ Daniel Dex, Attorney-in-Fact
Stock symbol
ZYME
Transactions as of
Nov 10, 2021
Transactions value $
$0
Form type
4
Date filed
11/12/2021, 08:00 PM
Previous filing
Jul 8, 2021
Next filing
Jan 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Award $0 +106K $0.00 106K Nov 10, 2021 Common Shares 106K $21.18 Direct F1
transaction ZYME Restricted Stock Unit Award $0 +17.7K $0.00 17.7K Nov 10, 2021 Common Shares 17.7K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3 The restricted stock units vest in three equal annual installments beginning on November 10, 2022.